ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

IMM Immupharma Plc

2.14
0.00 (0.00%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Immupharma Plc LSE:IMM London Ordinary Share GB0033711010 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 2.14 2.10 2.18 2.20 2.19 2.19 604,698 16:35:15
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Finance Services 0 -3.81M -0.0114 -1.93 7.33M
Immupharma Plc is listed in the Finance Services sector of the London Stock Exchange with ticker IMM. The last closing price for Immupharma was 2.14p. Over the last year, Immupharma shares have traded in a share price range of 0.83p to 3.78p.

Immupharma currently has 333,403,115 shares in issue. The market capitalisation of Immupharma is £7.33 million. Immupharma has a price to earnings ratio (PE ratio) of -1.93.

Immupharma Share Discussion Threads

Showing 7101 to 7122 of 39125 messages
Chat Pages: Latest  293  292  291  290  289  288  287  286  285  284  283  282  Older
DateSubjectAuthorDiscuss
11/12/2017
09:18
Market cap still a miserly £215m.....

That would be about right for the pipeline EXCLUDING Lupuzor IMO. DYOR etc.

qazwsxedc69
11/12/2017
09:17
going very nicely indeed....
qs99
11/12/2017
09:04
indeed...£2 and beyond looks very doable at this rate IMO...DYOR
qs99
11/12/2017
09:02
they can't keep up with demand
adejuk
11/12/2017
09:02
£1.60 Gone!
spmc
11/12/2017
08:54
I agree with Ham.. The spread seems to be quite wide on this one and with an upwards trend it might cost a fair bit to buy back. I bought some VELA this morning (actually lodged it over the weekend) and ended up paying 15% above because of the spread.
tricky red
11/12/2017
08:50
Yep, if you try profit taking and re-entry on this share, you are going to get caught out. This share is more gappy than Terry Thomas' front teeth (god rest is wonderful soul)
hamhamham1
11/12/2017
08:50
The risk reward here is unbelievable. I've only taken a small stake but this is surely a share everyone should have a nibble from.
mad foetus
11/12/2017
08:46
I had a target of £2.50-£5.00 before results but it appears the low end could reach in next couple of weeks. At current price still time to get in IMHO.
divinessence
11/12/2017
08:37
Grabbed a few more. IMM is the one to be in.
top tips
11/12/2017
08:26
Have you been topping up top tips? LOL
flavio_monteiro
11/12/2017
08:19
This is just the start. Its worth billions.
top tips
11/12/2017
08:19
I'm not selling any NYBoy for a long while don't worry. This is a hold extremely tight for me.
spawny100
11/12/2017
08:18
With most now completed the trial.looks like it could be good news next quarter
fidra
11/12/2017
08:17
Just hold until next Spring for substantive returns imho

Starting to warm up now on a cold blighty day.

ny boy
11/12/2017
08:12
Volume started out with a bang this morning
spawny100
11/12/2017
08:11
Only dear the day you buy it :-)
che7win
11/12/2017
08:08
Bit perky this morning for a dark damp cold Monday
spawny100
11/12/2017
08:04
175p next target
herschel k
10/12/2017
22:25
Edit: Majority of the patients showed resolution of the arthritis measure (4 point score).
money maker1
10/12/2017
22:23
An analyst said they understood the arthritis measures were "completely resolved" in the Phase 2b Lupuzor trial.
money maker1
10/12/2017
21:32
No problem Jpl, I was very excited when Tim said that!

Well the SLEDAI2k they are using measures arthritis as a symptom of lupus, and in the phase IIb trial there was 'promising' results on the arthritis measure indicating it could be used for that.

I can't remember ever finding the exact results of the arthritis measure in phase IIb, not sure if it was ever shared.

The asthma results from p140 were very strong in mice! And mice share 97.5% of their DNA with humans, so surely that's as good as a phase II trial ;)

asat91
Chat Pages: Latest  293  292  291  290  289  288  287  286  285  284  283  282  Older

Your Recent History

Delayed Upgrade Clock